PLoS Medicine (Aug 2021)

An open science pathway for drug marketing authorization-Registered drug approval.

  • Florian Naudet,
  • Maximilian Siebert,
  • Rémy Boussageon,
  • Ioana A Cristea,
  • Erick H Turner

DOI
https://doi.org/10.1371/journal.pmed.1003726
Journal volume & issue
Vol. 18, no. 8
p. e1003726

Abstract

Read online

Florian Naudet and co-authors propose a pathway involving registered criteria for evaluation and approval of new drugs.